Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Kyntra Bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 152 | 1 | 152 | +1 |
| Shares | 70.6M | 250 | 73.0M | +2.39M (+3.4%) |
| Value | $746.9M | $3.00K | $950.1M | +$203.2M (+27.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Kyntra Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 2,750,000 | $35.8M | 0.09% |
| Marshall Wace, LLP | 759,987 | $9.89M | 0.02% |
| Eagle Asset Management Inc | 738,630 | $9.61M | 0.06% |
| Massachusetts Financial Services Co | 85,813 | $1.12M | 0.00% |
| Tri Locum Partners LP | 74,348 | $967.0K | 0.28% |
| Occudo Quantitative Strategies LP | 69,347 | $902.0K | 0.07% |
| Schonfeld Strategic Advisors LLC | 49,579 | $645.0K | 0.01% |
| Victory Capital Management Inc | 44,030 | $573.0K | 0.00% |
| AQR Capital Management LLC | 40,266 | $524.0K | 0.00% |
| Mackenzie Financial Corp | 39,724 | $517.0K | 0.00% |
| Ameriprise Financial Inc | 27,666 | $360.0K | 0.00% |
| Gyon Technologies Capital Management, LP | 25,616 | $333.0K | 0.10% |
| Jump Financial, LLC | 14,200 | $185.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 12,660 | $165.0K | 0.00% |
| Axiom Investment Management LLC | 4,000 | $52.0K | 0.10% |
| China Universal Asset Management Co., Ltd. | 878 | $11.0K | 0.00% |
| Signaturefd, LLC | 66 | $1.00K | 0.00% |
| Geneos Wealth Management Inc. | 100 | $1.00K | 0.00% |
| Allworth Financial LP | 17 | $0 | 0.00% |
Sold out (18)
Institutions that held Kyntra Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tudor Investment Corp Et Al | 125,523 | $1.33M |
| Bank of Montreal | 106,215 | $1.24M |
| Long Focus Capital Management, LLC | 89,539 | $946.0K |
| HRT Financial LP | 60,356 | $637.0K |
| Dynamic Technology Lab Private Ltd | 45,725 | $483.0K |
| Gsa Capital Partners LLP | 39,275 | $415.0K |
| Bayesian Capital Management, LP | 17,882 | $189.0K |
| Quantamental Technologies LLC | 12,780 | $135.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 11,783 | $124.0K |
| Gotham Asset Management, LLC | 10,750 | $114.0K |
| Overbrook Management Corp | 10,370 | $110.0K |
| Lazard Asset Management LLC | 5,632 | $59.0K |
| Quantbot Technologies LP | 3,745 | $39.0K |
| Blume Capital Management, Inc. | 500 | $5.00K |
| Cubist Systematic Strategies, LLC | 335 | $4.00K |
| State of Wyoming | 50 | $1.00K |
| The PNC Financial Services Group, Inc. | 3 | $0 |
| Bell Investment Advisors, Inc | 25 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Kyntra Bio, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brewin Dolphin Wealth Management Ltd | 250 | $3.00K |